InvestorsHub Logo
icon url

Bourbon_on_my_cornflakes

10/19/23 10:41 AM

#435869 RE: bas2020 #435867

Here's the logic. First, Dr. M doesn't have to give the presentation. What happened to the chief medical officer, the chief science officer?

Second, if NDA filings were a priority, an NDA for alz should have been filed already.

And dont even go into the issue of getting things accomplished on time
icon url

Bourbon_on_my_cornflakes

10/19/23 12:10 PM

#435908 RE: bas2020 #435867

Anavex should be able to walk and chew gum at the same time. Other companies can. What is the purpose of the CMO and CSO if they can't take half a day to do a presentation. What the hell are they actually doing, since we know it is not getting data out in a timely manner, filing NDAs, or getting new trials for Parkinsons or the rare new disease started. These people have been paid for years with ZERO output.
icon url

raja48185

10/19/23 1:37 PM

#435929 RE: bas2020 #435867

As I recall, every time excellent results are presented at conferences, AF is waiting with a hit piece for another organized short attack. So why would they want to present at conferences?

So why did Anavex present at CTAD in 2022?